A 63-year-old man with a remote history of oropharyngeal cancer presented with a 1-year history of dysphagia, poor oral intake, and a 50-pound weight loss. On exam, he appeared cachectic with diffuse, symmetric scaling, most prominent over his lower extremities (Fig. 1a) . He denied associated pain or pruritus. Laboratory testing revealed an undetectable vitamin C level and markedly reduced levels of A, E, B1, and B6. Given his malnourished state, enteral nutrition via a percutaneous gastrostomy tube was initiated. His skin findings were thought to represent a form of acquired ichthyosis (AI) related to nutritional deficiency. Over time, he gained weight and his skin findings progressively improved, with complete resolution by month 6 (Fig. 1b) .
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Acquired ichthyosis is a non-hereditary cutaneous disorder characterized by rough, dry skin with prominent scaling.
1 Skin changes are the result of hyperkeratosis due to disruption of epidermal cornification. The underlying mechanism is debated, though impaired lipogenesis has been proposed. 2 AI is often associated with systemic disease, 6 including malignancy, autoimmune disease, and nutritional deficiency, in the form of either gross protein-energy malnutrition 3 or vitamin deficiency. 4, 5 The diagnosis is generally clinical, and treatment targets the underlying disease state, though lipid-rich lubricants and keratolytic agents can be useful adjuvants. 
